Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Latanoprost IP 0.005% w/v + Timlol 0.5% w/v Eye Drop
Dosage Form : Eye Drops
Packaging Type : Dropper
Packaging : 5ml
Price : ₹0/-
Latoshell T Eye Drop (Latanoprost 0.005% + Timolol 0.5%) is the gold-standard, high-profit chronic care product built for our PCD Pharma Franchise partners.
This Fixed-Dose Combination (FDC) is the most widely recognized and prescribed secondary/tertiary line treatment for Glaucoma, combining the powerful outflow enhancement of Latanoprost with the aqueous humor suppression of the Beta-Blocker Timolol. This rational combination offers maximum Intraocular Pressure (IOP) reduction in a single, once-daily drop.
Why Latoshell T is Your Key to Profit:
Guaranteed Perpetual Revenue: Glaucoma treatment is mandatory and lifelong. The FDC guarantees superior patient compliance (fewer drops daily) which ensures stable, predictable, perpetual refills and excellent financial stability.
Maximum Specialty Margin: Positioned as the gold-standard, specialized FDC in the critical ophthalmic segment, this product commands premium pricing and secures some of the highest profit margins in chronic eye care.
Superior Clinical Value: The FDC is clinically essential for patients needing aggressive IOP lowering. This essential status drives strong, reliable specialist loyalty and consistent high-volume orders.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this specific, gold-standard FDC formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.
Contact us today to capture this max-margin chronic specialty segment!
Common side effects may include transient burning or stinging upon instillation, redness, or itching of the eyes. Rarely, systemic effects or severe allergic reactions may occur.
Ketorine Eye Drop is indicated for the relief of pain and inflammation in the eyes following surgical procedures, as well as for treating allergic conjunctivitis and other inflammatory eye disorders.
For topical use only; do not ingest. Discontinue use and consult a healthcare professional if you experience severe irritation or an allergic reaction. Always follow your healthcare provider's instructions regarding dosage and application. Ketorine Eye Drop offers a targeted approach to managing ocular pain and inflammation, contributing to better patient outcomes and enhanced comfort during recovery. Always consult with a healthcare provider before starting any new medication.
Store at room temperature, away from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children.
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Paracetamol (100mg)
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Choline Salicylate (8.7% w/w) + Lidocaine (2.0% w/w)
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Cetirizine (10mg) + Phenylephrine (5mg) + Caffeine (25mg) Tablet
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg) Tablet
Composition : Paracetamol (I.R.) 300mg + Paracetamol (S.R.) 700mg